Your browser doesn't support javascript.
loading
Narcolepsy: Clinical Feature, Diagnosis and Treatment / 수면정신생리
Sleep Medicine and Psychophysiology ; : 63-68, 2010.
Article in Korean | WPRIM | ID: wpr-214074
ABSTRACT
Narcolepsy is a central neurologic system disease. It begins early in life with disabling symptoms including excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic hallucination and nocturnal sleep fragmentation. Patient with typical symptoms of narcolepsy is diagnosed by objective data from nocturnal polysomnography and multiple sleep latency tests. Narcolepsy is controlled with various medications. Nowadays, modafinil with favorable side effects profiles compared with traditional stimulant is mainly used. Gamma hydroxyl butyrate is effective in cataplexy. Cataplexy is also controlled with antidepressant such as Venlafaxine, SSRI, and TCA. As the knowledge of pathophysiology of narcolepsy expands, new treatment including immunological method, application of hypocretin and histamine systems have been tried.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Sleep Deprivation / Benzhydryl Compounds / Neuropeptides / Butyrates / Histamine / Cataplexy / Polysomnography / Sleep Paralysis / Cyclohexanols / Intracellular Signaling Peptides and Proteins Type of study: Diagnostic study Limits: Humans Language: Korean Journal: Sleep Medicine and Psychophysiology Year: 2010 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Sleep Deprivation / Benzhydryl Compounds / Neuropeptides / Butyrates / Histamine / Cataplexy / Polysomnography / Sleep Paralysis / Cyclohexanols / Intracellular Signaling Peptides and Proteins Type of study: Diagnostic study Limits: Humans Language: Korean Journal: Sleep Medicine and Psychophysiology Year: 2010 Type: Article